Clinical Trial Update: A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency [Phase 2]

View source ↗

Summary

A completed Phase 2 randomized, double-blind dose–response study evaluated the safety and uric acid–lowering effects of oral ulodesine added to allopurinol in s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Allopurinol (Allopurinol)
• Ulodesine (ulodesine)

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Gout, Hyperuricemia | Phase 2 | Status: COMPLETED